News
WXIBF
4.400
NaN%
--
WuXi Biologics Wins Full Shareholder Backing at 2026 AGM
TipRanks · 1h ago
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Wuxi Biologics (Cayman) (OtherWXIBF)
TipRanks · 13h ago
Wuxi Biologics Grants Time-Based Restricted Shares to 21 Employees
TipRanks · 1d ago
Guotai Haitong Sticks to Its Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 1d ago
Weekly Report: what happened at WXIBF last week (0601-0605)?
Weekly Report · 2d ago
Analysts Are Bullish on Top Healthcare Stocks: Autolus Therapeutics (AUTL), Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 06/03 00:20
CICC Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 06/02 05:18
Weekly Report: what happened at WXIBF last week (0525-0529)?
Weekly Report · 06/01 09:17
WuXi Biologics Schedules 2026 Business Update Calls for Investors
TipRanks · 05/31 10:07
Analysts Offer Insights on Healthcare Companies: CSPC Pharmaceutical Group (OtherCHJTF) and Wuxi Biologics (Cayman) (OtherWXIBF)
TipRanks · 05/30 00:20
UBS Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 05/28 00:41
WuXi Biologics Launches US$400 Million Share Buyback Plan
TipRanks · 05/26 00:15
Weekly Report: what happened at WXIBF last week (0518-0522)?
Weekly Report · 05/25 09:17
WuXi Biologics Sets 2026 AGM to Vote on Board, Auditors and New Share Mandate
TipRanks · 05/19 08:39
Weekly Report: what happened at WXIBF last week (0511-0515)?
Weekly Report · 05/18 09:17
Morgan Stanley Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 05/14 10:52
China's Next Phase In Healthcare Innovation
Seeking Alpha · 05/14 10:00
Weekly Report: what happened at WXIBF last week (0504-0508)?
Weekly Report · 05/11 09:16
Weekly Report: what happened at WXIBF last week (0427-0501)?
Weekly Report · 05/04 09:16
Weekly Report: what happened at WXIBF last week (0420-0424)?
Weekly Report · 04/27 09:17
More
Webull provides a variety of real-time WXIBF stock news. You can receive the latest news about Wuxi Bio through multiple platforms. This information may help you make smarter investment decisions.
About WXIBF
WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.